First Time Loading...

Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 149.27 USD -0.43% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

JNJ Price Targets Summary
Johnson & Johnson

Wall Street analysts forecast JNJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JNJ is 176.76 USD with a low forecast of 156.55 USD and a high forecast of 225.75 USD.

JNJ Lowest Forecast
Wall Street Target
156.55 USD
5% Upside
JNJ Average Forecast
Wall Street Target
176.76 USD
18% Upside
JNJ Highest Forecast
Wall Street Target
225.75 USD
51% Upside
Lowest
Price Target
156.55 USD
5% Upside
Average
Price Target
176.76 USD
18% Upside
Highest
Price Target
225.75 USD
51% Upside

JNJ Last Price Targets
Johnson & Johnson

The latest public price target was made on Apr 18, 2024 by Morten Herholdt from Johnson Rice , who expects JNJ stock to rise by 14% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Morten Herholdt
Johnson Rice
170 USD
Upside 14%
2 weeks ago
Apr 18, 2024
HSBC Upgrades Johnson & Johnson (JNJ) to Buy, 'Steady outlook, low expectations'
StreetInsider
Shagun Singh
RBC Capital
175 USD
Upside 17%
2 weeks ago
Apr 17, 2024
Johnson & Johnson (JNJ) PT Lowered to $175 at RBC Capital
StreetInsider
Louise Chen
Johnson Rice
215 USD
Upside 44%
2 weeks ago
Apr 17, 2024
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
Benzinga
Rick Wise
Stifel Nicolaus
155 USD
Upside 4%
2 weeks ago
Apr 16, 2024
Johnson & Johnson (JNJ) PT Lowered to $155 at Stifel
StreetInsider
Terence Flynn
Morgan Stanley
169 USD
Upside 13%
1 month ago
Mar 27, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga
Jayson Bedford
Raymond James
175 USD
Upside 17%
1 month ago
Mar 27, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga
Jayson Bedford
Raymond James
110 USD
Downside 26%
4 months ago
Dec 28, 2023
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Benzinga
Larry Biegelsen
Wells Fargo
163 USD
Upside 9%
4 months ago
Dec 28, 2023
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Benzinga
Shagun Singh
Johnson Rice
178 USD
Upside 19%
7 months ago
Oct 5, 2023
Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst
Benzinga
Trung Huynh
Johnson Rice
175 USD
Upside 17%
9 months ago
Jul 21, 2023
Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance
Benzinga
John Ransom
Raymond James
90 USD
Downside 40%
11 months ago
May 24, 2023
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Benzinga
Show More Price Targets
Show Less Price Targets
Morten Herholdt
Johnson Rice
Price Target 170 USD
Upside/Downside 14%
View Source
Shagun Singh
RBC Capital
Price Target 175 USD
Upside/Downside 17%
View Source
Louise Chen
Johnson Rice
Price Target 215 USD
Upside/Downside 44%
View Source
Rick Wise
Stifel Nicolaus
Price Target 155 USD
Upside/Downside 4%
View Source
Terence Flynn
Morgan Stanley
Price Target 169 USD
Upside/Downside 13%
View Source
Jayson Bedford
Raymond James
Price Target 175 USD
Upside/Downside 17%
View Source
Jayson Bedford
Raymond James
Price Target 110 USD
Upside/Downside 26%
View Source
Larry Biegelsen
Wells Fargo
Price Target 163 USD
Upside/Downside 9%
View Source
Shagun Singh
Johnson Rice
Price Target 178 USD
Upside/Downside 19%
View Source
Trung Huynh
Johnson Rice
Price Target 175 USD
Upside/Downside 17%
View Source
John Ransom
Raymond James
Price Target 90 USD
Upside/Downside 40%
View Source
Show More Price Targets
Show Less Price Targets
Johnson & Johnson Competitors:
Price Targets
C
CURA
Curaleaf Holdings Inc
29% Upside
KLBF
Kalbe Farma Tbk PT
21% Upside
A
605116
Aurisco Pharmaceutical Co Ltd
30% Upside
P
PLTH
Planet 13 Holdings Inc
181% Upside
C
CURA
Curaleaf Holdings Inc
29% Upside
KLBF
Kalbe Farma Tbk PT
21% Upside
A
605116
Aurisco Pharmaceutical Co Ltd
30% Upside
P
PLTH
Planet 13 Holdings Inc
181% Upside
600594
Guizhou Yibai Pharmaceutical Co Ltd
57% Upside
002020
Zhejiang Jingxin Pharmaceutical Co Ltd
12% Upside
C
072020
Choong Ang Vaccine Laboratory
46% Upside
D
000640
Dong-A Socio Holdings Co Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's revenue is 2%. The projected CAGR for the next 3 years is 4%.

2%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's operating income is 2%. The projected CAGR for the next 3 years is 9%.

2%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's net income is 11%. The projected CAGR for the next 3 years is -7%.

11%
Past Growth
-7%
Estimated Growth
Estimates Accuracy
-24%
Average Miss
What are analyst estimates?

See Also

Summary
JNJ intrinsic value, competitors valuation, and company profile.
DCF Valuation
JNJ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JNJ stock valuation using valuation multiples.
Wall Street Estimates
JNJ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JNJ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JNJ's stock price target?
Price Target
176.76 USD

According to Wall Street analysts, the average 1-year price target for JNJ is 176.76 USD with a low forecast of 156.55 USD and a high forecast of 225.75 USD.

What is Johnson & Johnson's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Johnson & Johnson's revenue is 2%. The projected CAGR for the next 3 years is 4%.

What is Johnson & Johnson's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Johnson & Johnson's operating income is 2%. The projected CAGR for the next 3 years is 9%.

What is Johnson & Johnson's Net Income forecast?
Projected CAGR
-7%

For the last 8 years the compound annual growth rate for Johnson & Johnson's net income is 11%. The projected CAGR for the next 3 years is -7%.

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.